← Back to Search

Monofocal Intraocular Lens

Eyhance IOL for Presbyopia

N/A
Waitlist Available
Led By Kerry D Solomon
Research Sponsored by Carolina Eyecare Physicians, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a special lens implanted during cataract surgery to improve vision. It targets patients with or without astigmatism and aims to see if focusing both eyes for distance or one eye for near vision works better.

Eligible Conditions
  • Presbyopia
  • Pseudoaphakia
  • Cataract

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mini monovisionExperimental Treatment1 Intervention
The target refraction for the dominant eye will be plano (± 0.25 D) and for the non-dominant eye between -0.75D ±0.15.
Group II: EmmetropiaActive Control1 Intervention
The target refraction for both eyes will be emmetropia (± 0.25 D).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Eyhance IOL
2021
N/A
~280

Find a Location

Who is running the clinical trial?

Carolina Eyecare Physicians, LLCLead Sponsor
10 Previous Clinical Trials
537 Total Patients Enrolled
2 Trials studying Presbyopia
72 Patients Enrolled for Presbyopia
Kerry D SolomonPrincipal InvestigatorCarolina Eyecare Physicians
~18 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top